Glycogen Storage Disease Type I
Information
- Disease name
- Glycogen Storage Disease Type I
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03665636 | Completed | Early Phase 1 | Anaplerotic Therapy Using Triheptanoin for Patients With Glycogen Storage Disease Type I | October 16, 2020 | October 21, 2021 |
| NCT03871673 | Completed | N/A | The Use of Uncooked Sweet Manioc Starch to Treat Hepatic Glycogen Storage Diseases | April 29, 2017 | May 31, 2021 |
| NCT03655223 | Enrolling by invitation | Early Check: Expanded Screening in Newborns | October 15, 2018 | December 31, 2025 | |
| NCT04138251 | Unknown status | Phase 2 | Safety, Efficacy Evaluation of Empagliflozin Administration for Neutropenia in Glycogenosis Type 1b and G6PC3 Deficiency | June 20, 2019 | June 30, 2020 |
| NCT02385162 | Withdrawn | Biomarker for Glycogen Storage Diseases (BioGlycogen) | August 20, 2018 | February 28, 2021 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D005953